- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Brucellosis Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Brucellosis Vaccines market size is estimated to be worth US$ 11 million in 2021 and is forecast to a readjusted size of USD 14 million by 2028 with a CAGR of 3.5% during review period. Cattle accounting for % of the Brucellosis Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While S19 Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Brucellosis Vaccines include Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, and Vetal Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Brucellosis Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
S19 Vaccine
RB51 Vaccine Strain
Market segment by Application can be divided into
Cattle
Sheep
Others
The key market players for global Brucellosis Vaccines market are listed below:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Brucellosis Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Brucellosis Vaccines, with price, sales, revenue and global market share of Brucellosis Vaccines from 2019 to 2022.
Chapter 3, the Brucellosis Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Brucellosis Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Brucellosis Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Brucellosis Vaccines.
Chapter 13, 14, and 15, to describe Brucellosis Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Brucellosis Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Brucellosis Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 S19 Vaccine
1.2.3 RB51 Vaccine Strain
1.3 Market Analysis by Application
1.3.1 Overview: Global Brucellosis Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Others
1.4 Global Brucellosis Vaccines Market Size & Forecast
1.4.1 Global Brucellosis Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Brucellosis Vaccines Sales in Volume (2017-2028)
1.4.3 Global Brucellosis Vaccines Price (2017-2028)
1.5 Global Brucellosis Vaccines Production Capacity Analysis
1.5.1 Global Brucellosis Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Brucellosis Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Brucellosis Vaccines Market Drivers
1.6.2 Brucellosis Vaccines Market Restraints
1.6.3 Brucellosis Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Jinyu
2.1.1 Jinyu Details
2.1.2 Jinyu Major Business
2.1.3 Jinyu Brucellosis Vaccines Product and Services
2.1.4 Jinyu Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Colorado Serum
2.2.1 Colorado Serum Details
2.2.2 Colorado Serum Major Business
2.2.3 Colorado Serum Brucellosis Vaccines Product and Services
2.2.4 Colorado Serum Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Brucellosis Vaccines Product and Services
2.3.4 Boehringer Ingelheim Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Biogenesis-Bago
2.4.1 Biogenesis-Bago Details
2.4.2 Biogenesis-Bago Major Business
2.4.3 Biogenesis-Bago Brucellosis Vaccines Product and Services
2.4.4 Biogenesis-Bago Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Vetal Company
2.5.1 Vetal Company Details
2.5.2 Vetal Company Major Business
2.5.3 Vetal Company Brucellosis Vaccines Product and Services
2.5.4 Vetal Company Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 CZ Veterinaria
2.6.1 CZ Veterinaria Details
2.6.2 CZ Veterinaria Major Business
2.6.3 CZ Veterinaria Brucellosis Vaccines Product and Services
2.6.4 CZ Veterinaria Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 SYVA Laboratorios
2.7.1 SYVA Laboratorios Details
2.7.2 SYVA Laboratorios Major Business
2.7.3 SYVA Laboratorios Brucellosis Vaccines Product and Services
2.7.4 SYVA Laboratorios Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Indian Immunologicals
2.8.1 Indian Immunologicals Details
2.8.2 Indian Immunologicals Major Business
2.8.3 Indian Immunologicals Brucellosis Vaccines Product and Services
2.8.4 Indian Immunologicals Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Qilu
2.9.1 Qilu Details
2.9.2 Qilu Major Business
2.9.3 Qilu Brucellosis Vaccines Product and Services
2.9.4 Qilu Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Tecnovax
2.10.1 Tecnovax Details
2.10.2 Tecnovax Major Business
2.10.3 Tecnovax Brucellosis Vaccines Product and Services
2.10.4 Tecnovax Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hester Biosciences
2.11.1 Hester Biosciences Details
2.11.2 Hester Biosciences Major Business
2.11.3 Hester Biosciences Brucellosis Vaccines Product and Services
2.11.4 Hester Biosciences Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Zoetis
2.12.1 Zoetis Details
2.12.2 Zoetis Major Business
2.12.3 Zoetis Brucellosis Vaccines Product and Services
2.12.4 Zoetis Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Onderstepoort Biological
2.13.1 Onderstepoort Biological Details
2.13.2 Onderstepoort Biological Major Business
2.13.3 Onderstepoort Biological Brucellosis Vaccines Product and Services
2.13.4 Onderstepoort Biological Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Instituto Rosenbusch
2.14.1 Instituto Rosenbusch Details
2.14.2 Instituto Rosenbusch Major Business
2.14.3 Instituto Rosenbusch Brucellosis Vaccines Product and Services
2.14.4 Instituto Rosenbusch Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Ceva Sante Animale
2.15.1 Ceva Sante Animale Details
2.15.2 Ceva Sante Animale Major Business
2.15.3 Ceva Sante Animale Brucellosis Vaccines Product and Services
2.15.4 Ceva Sante Animale Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Calier & Biologicos Laverlam
2.16.1 Calier & Biologicos Laverlam Details
2.16.2 Calier & Biologicos Laverlam Major Business
2.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Product and Services
2.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Biovet
2.17.1 Biovet Details
2.17.2 Biovet Major Business
2.17.3 Biovet Brucellosis Vaccines Product and Services
2.17.4 Biovet Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Brucellosis Vaccines Breakdown Data by Manufacturer
3.1 Global Brucellosis Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Brucellosis Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Brucellosis Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Brucellosis Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Brucellosis Vaccines Manufacturer Market Share in 2021
3.5 Global Brucellosis Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Brucellosis Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Brucellosis Vaccines Market Size by Region
4.1.1 Global Brucellosis Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Brucellosis Vaccines Revenue by Region (2017-2028)
4.2 North America Brucellosis Vaccines Revenue (2017-2028)
4.3 Europe Brucellosis Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Brucellosis Vaccines Revenue (2017-2028)
4.5 South America Brucellosis Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Brucellosis Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Brucellosis Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Brucellosis Vaccines Revenue by Type (2017-2028)
5.3 Global Brucellosis Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Brucellosis Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Brucellosis Vaccines Revenue by Application (2017-2028)
6.3 Global Brucellosis Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Brucellosis Vaccines Sales by Type (2017-2028)
7.2 North America Brucellosis Vaccines Sales by Application (2017-2028)
7.3 North America Brucellosis Vaccines Market Size by Country
7.3.1 North America Brucellosis Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Brucellosis Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Brucellosis Vaccines Sales by Type (2017-2028)
8.2 Europe Brucellosis Vaccines Sales by Application (2017-2028)
8.3 Europe Brucellosis Vaccines Market Size by Country
8.3.1 Europe Brucellosis Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Brucellosis Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Brucellosis Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Brucellosis Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Brucellosis Vaccines Market Size by Region
9.3.1 Asia-Pacific Brucellosis Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Brucellosis Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Brucellosis Vaccines Sales by Type (2017-2028)
10.2 South America Brucellosis Vaccines Sales by Application (2017-2028)
10.3 South America Brucellosis Vaccines Market Size by Country
10.3.1 South America Brucellosis Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Brucellosis Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Brucellosis Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Brucellosis Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Brucellosis Vaccines Market Size by Country
11.3.1 Middle East & Africa Brucellosis Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Brucellosis Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Brucellosis Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Brucellosis Vaccines
12.3 Brucellosis Vaccines Production Process
12.4 Brucellosis Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Brucellosis Vaccines Typical Distributors
13.3 Brucellosis Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Brucellosis Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Brucellosis Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Jinyu Basic Information, Manufacturing Base and Competitors
Table 4. Jinyu Major Business
Table 5. Jinyu Brucellosis Vaccines Product and Services
Table 6. Jinyu Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Colorado Serum Basic Information, Manufacturing Base and Competitors
Table 8. Colorado Serum Major Business
Table 9. Colorado Serum Brucellosis Vaccines Product and Services
Table 10. Colorado Serum Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Brucellosis Vaccines Product and Services
Table 14. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Biogenesis-Bago Basic Information, Manufacturing Base and Competitors
Table 16. Biogenesis-Bago Major Business
Table 17. Biogenesis-Bago Brucellosis Vaccines Product and Services
Table 18. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Vetal Company Basic Information, Manufacturing Base and Competitors
Table 20. Vetal Company Major Business
Table 21. Vetal Company Brucellosis Vaccines Product and Services
Table 22. Vetal Company Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. CZ Veterinaria Basic Information, Manufacturing Base and Competitors
Table 24. CZ Veterinaria Major Business
Table 25. CZ Veterinaria Brucellosis Vaccines Product and Services
Table 26. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. SYVA Laboratorios Basic Information, Manufacturing Base and Competitors
Table 28. SYVA Laboratorios Major Business
Table 29. SYVA Laboratorios Brucellosis Vaccines Product and Services
Table 30. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 32. Indian Immunologicals Major Business
Table 33. Indian Immunologicals Brucellosis Vaccines Product and Services
Table 34. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Qilu Basic Information, Manufacturing Base and Competitors
Table 36. Qilu Major Business
Table 37. Qilu Brucellosis Vaccines Product and Services
Table 38. Qilu Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Tecnovax Basic Information, Manufacturing Base and Competitors
Table 40. Tecnovax Major Business
Table 41. Tecnovax Brucellosis Vaccines Product and Services
Table 42. Tecnovax Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Hester Biosciences Basic Information, Manufacturing Base and Competitors
Table 44. Hester Biosciences Major Business
Table 45. Hester Biosciences Brucellosis Vaccines Product and Services
Table 46. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Zoetis Basic Information, Manufacturing Base and Competitors
Table 48. Zoetis Major Business
Table 49. Zoetis Brucellosis Vaccines Product and Services
Table 50. Zoetis Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Onderstepoort Biological Basic Information, Manufacturing Base and Competitors
Table 52. Onderstepoort Biological Major Business
Table 53. Onderstepoort Biological Brucellosis Vaccines Product and Services
Table 54. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Instituto Rosenbusch Basic Information, Manufacturing Base and Competitors
Table 56. Instituto Rosenbusch Major Business
Table 57. Instituto Rosenbusch Brucellosis Vaccines Product and Services
Table 58. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Ceva Sante Animale Basic Information, Manufacturing Base and Competitors
Table 60. Ceva Sante Animale Major Business
Table 61. Ceva Sante Animale Brucellosis Vaccines Product and Services
Table 62. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Calier & Biologicos Laverlam Basic Information, Manufacturing Base and Competitors
Table 64. Calier & Biologicos Laverlam Major Business
Table 65. Calier & Biologicos Laverlam Brucellosis Vaccines Product and Services
Table 66. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Biovet Basic Information, Manufacturing Base and Competitors
Table 68. Biovet Major Business
Table 69. Biovet Brucellosis Vaccines Product and Services
Table 70. Biovet Brucellosis Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Brucellosis Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 72. Global Brucellosis Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Brucellosis Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Brucellosis Vaccines Production Capacity by Company, (M Doses): 2020 VS 2021
Table 75. Head Office and Brucellosis Vaccines Production Site of Key Manufacturer
Table 76. Brucellosis Vaccines New Entrant and Capacity Expansion Plans
Table 77. Brucellosis Vaccines Mergers & Acquisitions in the Past Five Years
Table 78. Global Brucellosis Vaccines Sales by Region (2017-2022) & (M Doses)
Table 79. Global Brucellosis Vaccines Sales by Region (2023-2028) & (M Doses)
Table 80. Global Brucellosis Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Brucellosis Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 83. Global Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 84. Global Brucellosis Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Brucellosis Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Brucellosis Vaccines Price by Type (2017-2022) & (USD/K Doses)
Table 87. Global Brucellosis Vaccines Price by Type (2023-2028) & (USD/K Doses)
Table 88. Global Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 89. Global Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 90. Global Brucellosis Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Brucellosis Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Brucellosis Vaccines Price by Application (2017-2022) & (USD/K Doses)
Table 93. Global Brucellosis Vaccines Price by Application (2023-2028) & (USD/K Doses)
Table 94. North America Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
Table 95. North America Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
Table 96. North America Brucellosis Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Brucellosis Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 99. North America Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 100. North America Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 101. North America Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 102. Europe Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
Table 103. Europe Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
Table 104. Europe Brucellosis Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Brucellosis Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 107. Europe Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 108. Europe Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 109. Europe Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 110. Asia-Pacific Brucellosis Vaccines Sales by Region (2017-2022) & (M Doses)
Table 111. Asia-Pacific Brucellosis Vaccines Sales by Region (2023-2028) & (M Doses)
Table 112. Asia-Pacific Brucellosis Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Brucellosis Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 115. Asia-Pacific Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 116. Asia-Pacific Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 117. Asia-Pacific Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 118. South America Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
Table 119. South America Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
Table 120. South America Brucellosis Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Brucellosis Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 123. South America Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 124. South America Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 125. South America Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 126. Middle East & Africa Brucellosis Vaccines Sales by Region (2017-2022) & (M Doses)
Table 127. Middle East & Africa Brucellosis Vaccines Sales by Region (2023-2028) & (M Doses)
Table 128. Middle East & Africa Brucellosis Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Brucellosis Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 131. Middle East & Africa Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 132. Middle East & Africa Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 133. Middle East & Africa Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 134. Brucellosis Vaccines Raw Material
Table 135. Key Manufacturers of Brucellosis Vaccines Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Brucellosis Vaccines Typical Distributors
Table 139. Brucellosis Vaccines Typical Customers
List of Figures
Figure 1. Brucellosis Vaccines Picture
Figure 2. Global Brucellosis Vaccines Revenue Market Share by Type in 2021
Figure 3. S19 Vaccine
Figure 4. RB51 Vaccine Strain
Figure 5. Global Brucellosis Vaccines Revenue Market Share by Application in 2021
Figure 6. Cattle
Figure 7. Sheep
Figure 8. Others
Figure 9. Global Brucellosis Vaccines Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 10. Global Brucellosis Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Brucellosis Vaccines Sales (2017-2028) & (M Doses)
Figure 12. Global Brucellosis Vaccines Price (2017-2028) & (USD/K Doses)
Figure 13. Global Brucellosis Vaccines Production Capacity (2017-2028) & (M Doses)
Figure 14. Global Brucellosis Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Brucellosis Vaccines Market Drivers
Figure 16. Brucellosis Vaccines Market Restraints
Figure 17. Brucellosis Vaccines Market Trends
Figure 18. Global Brucellosis Vaccines Sales Market Share by Manufacturer in 2021
Figure 19. Global Brucellosis Vaccines Revenue Market Share by Manufacturer in 2021
Figure 20. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Brucellosis Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Brucellosis Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Brucellosis Vaccines Sales Market Share by Region (2017-2028)
Figure 24. Global Brucellosis Vaccines Revenue Market Share by Region (2017-2028)
Figure 25. North America Brucellosis Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Europe Brucellosis Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Brucellosis Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. South America Brucellosis Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Brucellosis Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Global Brucellosis Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Brucellosis Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Brucellosis Vaccines Price by Type (2017-2028) & (USD/K Doses)
Figure 33. Global Brucellosis Vaccines Sales Market Share by Application (2017-2028)
Figure 34. Global Brucellosis Vaccines Revenue Market Share by Application (2017-2028)
Figure 35. Global Brucellosis Vaccines Price by Application (2017-2028) & (USD/K Doses)
Figure 36. North America Brucellosis Vaccines Sales Market Share by Type (2017-2028)
Figure 37. North America Brucellosis Vaccines Sales Market Share by Application (2017-2028)
Figure 38. North America Brucellosis Vaccines Sales Market Share by Country (2017-2028)
Figure 39. North America Brucellosis Vaccines Revenue Market Share by Country (2017-2028)
Figure 40. United States Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Brucellosis Vaccines Sales Market Share by Type (2017-2028)
Figure 44. Europe Brucellosis Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Brucellosis Vaccines Sales Market Share by Country (2017-2028)
Figure 46. Europe Brucellosis Vaccines Revenue Market Share by Country (2017-2028)
Figure 47. Germany Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Brucellosis Vaccines Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Brucellosis Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Brucellosis Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Brucellosis Vaccines Revenue Market Share by Region (2017-2028)
Figure 56. China Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Brucellosis Vaccines Sales Market Share by Type (2017-2028)
Figure 63. South America Brucellosis Vaccines Sales Market Share by Application (2017-2028)
Figure 64. South America Brucellosis Vaccines Sales Market Share by Country (2017-2028)
Figure 65. South America Brucellosis Vaccines Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Brucellosis Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Brucellosis Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Brucellosis Vaccines Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Brucellosis Vaccines Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Brucellosis Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Brucellosis Vaccines in 2021
Figure 77. Manufacturing Process Analysis of Brucellosis Vaccines
Figure 78. Brucellosis Vaccines Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
